MedPath

PEGASYS RBV

PEGASYS RBV

Discontinued
DIN Number

02253429

Drug Class

Human

Market Date

May 26, 2004

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02253429
AIG Number0250103001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L03AB61 PEGINTERFERON ALFA-2A, COMBINATIONS
Product Specifications
Dosage FormTablet ,  Solution
Route of AdministrationOral ,  Subcutaneous
AHFS Classification08:18.32
Health Canada Classification

ACTIVE INGREDIENTS (2)

PEGINTERFERON ALFA-2AActive
Strength: 180 MCG / 0.5 ML
Monograph: PEGINTERFERON ALFA-2A
RIBAVIRINActive
Strength: 200 MG / TAB
Monograph: RIBAVIRIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.